HANA CHOI-NGUYEN: Open Payments
NPI 1821227505 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $193 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $103 |
| ORPHALAN INC | 3 | $77 |
| Mirum Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Livdelzi, CUVRIOR, Livmarli, TEFLARO, MAVYRET, ULTOMIRIS, Wegovy.
Industry payments across TX — which companies pay providers there.
